
Patricia L Morris
Examiner (ID: 4560, Phone: (571)272-0688 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1203, 1612, 1201, 1625, 1209 |
| Total Applications | 3798 |
| Issued Applications | 2697 |
| Pending Applications | 142 |
| Abandoned Applications | 965 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14119147
[patent_doc_number] => 10246418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-02
[patent_title] => Crystal form of lenvatinib methanesulfonate salt and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 15/575352
[patent_app_country] => US
[patent_app_date] => 2016-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 2091
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575352
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/575352 | Crystal form of lenvatinib methanesulfonate salt and preparation method thereof | Jun 7, 2016 | Issued |
Array
(
[id] => 12680623
[patent_doc_number] => 20180118707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => BETA-NAPHTHOISOFLAVONES, COMPOSITIONS CONTAINING, AND USES OF, SAME
[patent_app_type] => utility
[patent_app_number] => 15/735053
[patent_app_country] => US
[patent_app_date] => 2016-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -105
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15735053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/735053 | BETA-NAPHTHOISOFLAVONES, COMPOSITIONS CONTAINING, AND USES OF, SAME | Jun 6, 2016 | Abandoned |
Array
(
[id] => 14818327
[patent_doc_number] => 10406149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Aqueous liquid formulation
[patent_app_type] => utility
[patent_app_number] => 15/578764
[patent_app_country] => US
[patent_app_date] => 2016-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6643
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578764
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/578764 | Aqueous liquid formulation | Jun 1, 2016 | Issued |
Array
(
[id] => 12790573
[patent_doc_number] => 20180155360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => ETHER ANALOGUES OF GALIELLALACTONE
[patent_app_type] => utility
[patent_app_number] => 15/578589
[patent_app_country] => US
[patent_app_date] => 2016-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578589
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/578589 | Ether analogues of galiellalactone | Jun 1, 2016 | Issued |
Array
(
[id] => 12812989
[patent_doc_number] => 20180162833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => PROCESS FOR THE PREPARATION OF EFINACONAZOLE
[patent_app_type] => utility
[patent_app_number] => 15/577818
[patent_app_country] => US
[patent_app_date] => 2016-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577818
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/577818 | Process for the preparation of efinaconazole | May 31, 2016 | Issued |
Array
(
[id] => 15606155
[patent_doc_number] => 10584127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => 3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 15/578460
[patent_app_country] => US
[patent_app_date] => 2016-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 31
[patent_no_of_words] => 49230
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578460
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/578460 | 3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists | May 30, 2016 | Issued |
Array
(
[id] => 11463788
[patent_doc_number] => 09580405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Processes for the preparation of pesticidal compounds'
[patent_app_type] => utility
[patent_app_number] => 15/166784
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16857
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15166784
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/166784 | Processes for the preparation of pesticidal compounds | May 26, 2016 | Issued |
Array
(
[id] => 11568552
[patent_doc_number] => 20170107197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'PHENYL-SUBSTITUTED NICOTINIC LIGANDS, AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/162237
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 23708
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15162237
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/162237 | Phenyl-substituted nicotinic ligands, and methods of use thereof | May 22, 2016 | Issued |
Array
(
[id] => 12112745
[patent_doc_number] => 09868726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'Pyridyl benzothiophenes as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/162172
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28935
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15162172
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/162172 | Pyridyl benzothiophenes as kinase inhibitors | May 22, 2016 | Issued |
Array
(
[id] => 11596024
[patent_doc_number] => 09643169
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-05-09
[patent_title] => 'Process for the preparation of quinoline based ionic fluoride salts (QUFS)'
[patent_app_type] => utility
[patent_app_number] => 15/158867
[patent_app_country] => US
[patent_app_date] => 2016-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 6634
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158867
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/158867 | Process for the preparation of quinoline based ionic fluoride salts (QUFS) | May 18, 2016 | Issued |
Array
(
[id] => 12706717
[patent_doc_number] => 20180127405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/574506
[patent_app_country] => US
[patent_app_date] => 2016-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574506
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/574506 | COMPOUNDS | May 18, 2016 | Abandoned |
Array
(
[id] => 12706618
[patent_doc_number] => 20180127372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES
[patent_app_type] => utility
[patent_app_number] => 15/574967
[patent_app_country] => US
[patent_app_date] => 2016-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574967
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/574967 | Amidoheteroaryl aroyl hydrazide ethynes | May 17, 2016 | Issued |
Array
(
[id] => 11059483
[patent_doc_number] => 20160256445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'DIHYDROPYRIDINONE MGAT2 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/154210
[patent_app_country] => US
[patent_app_date] => 2016-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36477
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15154210
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/154210 | DIHYDROPYRIDINONE MGAT2 INHIBITORS | May 12, 2016 | Abandoned |
Array
(
[id] => 11612517
[patent_doc_number] => 09650366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/152404
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17784
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15152404
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/152404 | Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors | May 10, 2016 | Issued |
Array
(
[id] => 11054352
[patent_doc_number] => 20160251314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => '2-[[[2-[(HYDROXYACETYL)AMINO]-4-PYRIDINYL]METHYL]THIO]-N-[4-(TRIFLUOROMETHOXY)PHENYL]-3-PYRIDINECARBOXAMIDE BENZENESULFONATE, CRYSTAL OF SAME, CRYSTAL POLYMORPH THEREOF, AND METHODS FOR PRODUCTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/150901
[patent_app_country] => US
[patent_app_date] => 2016-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8559
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15150901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/150901 | 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof | May 9, 2016 | Issued |
Array
(
[id] => 12728536
[patent_doc_number] => 20180134679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/572439
[patent_app_country] => US
[patent_app_date] => 2016-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15572439
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/572439 | Therapeutic compounds and methods of use thereof | May 8, 2016 | Issued |
Array
(
[id] => 11450299
[patent_doc_number] => 09573931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-21
[patent_title] => 'Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine'
[patent_app_type] => utility
[patent_app_number] => 15/145152
[patent_app_country] => US
[patent_app_date] => 2016-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1864
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15145152
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/145152 | Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine | May 2, 2016 | Issued |
Array
(
[id] => 11047500
[patent_doc_number] => 20160244458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'Crystals of Dispiropyrrolidine Derivatives'
[patent_app_type] => utility
[patent_app_number] => 15/144485
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11930
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144485
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/144485 | Crystals of dispiropyrrolidine derivatives | May 1, 2016 | Issued |
Array
(
[id] => 11463789
[patent_doc_number] => 09580406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Processes for the preparation of axitinib'
[patent_app_type] => utility
[patent_app_number] => 15/139494
[patent_app_country] => US
[patent_app_date] => 2016-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4112
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15139494
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/139494 | Processes for the preparation of axitinib | Apr 26, 2016 | Issued |
Array
(
[id] => 11429007
[patent_doc_number] => 09567315
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-02-14
[patent_title] => 'Method for synthesis of 4-OH substituted anabaseine derivative'
[patent_app_type] => utility
[patent_app_number] => 15/136066
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2958
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15136066
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/136066 | Method for synthesis of 4-OH substituted anabaseine derivative | Apr 21, 2016 | Issued |